KJ: Panel to decide on AstraZeneca vaccine


PETALING JAYA: Malaysia will decide on the use of the AstraZeneca vaccine for Covid-19 following a report by the European Medicines Agency (EMA) of rare blood clots being a possible side effect, says Science, Technology and Innovation Minister Khairy Jamaluddin.

“We take note of the EMA announcement on the AstraZeneca vaccine. @JKJAVMY will deliberate on the matter and decide if we will go ahead with using AZ in our portfolio of vaccines, ” he tweeted yesterday.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Vaccine , AstraZeneca , EMA , Medicine , Khairy Jamaluddin

   

Next In Nation

Advancing social protections to bring diversity and inclusion for women in Malaysia’s workforce
RHB sets its sights on net zero by 2050
Disability, the neglected piece of the DEI puzzle
Exploring the impact of purpose on brand growth in South-East Asia
Is the construction industry just a ‘boys’ club’?
Remembering marginalised Malaysians
Don’t tire yourself singing for three hours, fans urge Cheung
MACC probing Mahathir
Indonesia, Johor to boost trade, tourism
Pak Lah warded at IJN, in stable condition, says KJ

Others Also Read